Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures

Michael J Mack1, Phillip P Brown, Aaron D Kugelmass

  • 1Medical City Dallas Hospital, Dallas, Texas, USA. mjmack@earthlink.net

Insights

Percutaneous coronary intervention (PCI) is increasingly used for coronary artery disease over coronary artery bypass grafting (CABG). While CABG treats more complex cases, PCI shows lower mortality and complication rates, with outcomes continually improving.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Services Research

Background:

  • Practices and outcomes for coronary revascularization via surgical (CABG) and percutaneous (PCI) interventions are evolving.
  • Understanding current trends and early results is crucial for patient care and resource allocation.

Purpose of the Study:

  • To analyze trends in PCI versus CABG utilization from 1999-2002.
  • To compare early outcomes, including mortality and complications, between PCI and CABG procedures.
  • To assess the changing landscape of coronary artery disease interventions.

Main Methods:

  • A retrospective analysis of 148,396 patients undergoing PCI or CABG across 69 hospitals.
  • Data extracted from the HCA Casemix Database, utilizing ICD-9 coding for conditions and outcomes.
  • Logistic regression was employed to calculate odds ratios for death and complications, adjusting for numerous patient and procedural factors.

Main Results:

  • PCI volume increased by 6.8% annually, becoming 65.4% of all coronary revascularizations, while CABG volume declined.
  • PCI was predominantly used for single-vessel disease (83%), whereas CABG focused on multivessel disease (3.38 bypasses/patient).
  • PCI patients experienced lower unadjusted mortality (1.25% vs. 2.63%) and significantly fewer acute renal failure, neurologic, and cardiac complications compared to CABG patients.

Conclusions:

  • PCI utilization continues to rise relative to CABG for coronary artery disease treatment.
  • Despite CABG treating more complex multivessel disease, PCI demonstrates superior safety profiles with lower mortality and complication rates.
  • The disparity in adverse outcomes between CABG and PCI is narrowing, indicating ongoing improvements in both intervention types.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...